Gain Therapeutics, Inc.GANX
Key ratios
FCF / Sales
-34223.1%2023
ROA
-67.0%2025
2024
-82.8%2023
-65.1%
ROE
-268.3%TTM
2025
-155.7%2024
-205.0%2023
-141.6%
Revenue growth
-100.0%TTM
2023
-58.4%
Recent news
Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update
Track GANX in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer